Innovaccer
Innovaccer raises $275M Series F at $3.2B valuation
Quick Facts
Innovaccer: Series F Funding Round
Innovaccer has successfully raised $275M in Series F funding, reaching a valuation of $3.2B.
Company Overview
Healthcare data activation platform
Funding Details
The Series F round was led by General Catalyst, with participation from Tiger Global, Steadview Capital.
Company Information
- Headquarters: San Francisco, CA
- Founded: 2014
- Employees: 1500+
- Category: HealthTech
Investment
Innovaccer plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- General Catalyst: Verified investor in Series F
- Tiger Global: Verified investor in Series F
- Steadview Capital: Verified investor in Series F
Key Investors
About the Author
Related Company Reports
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
